Dana Alexander
Equibles does not estimate personal net worth.
About Dana Alexander
Obsidian Therapeutics, Inc. reported in an 8-K filed August 3, 2026 that Dana Alexander was appointed Chief Technical Officer, effective July 31, 2026. Obsidian Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Obsidian Therapeutics, Inc. includes Madan Jagasia (CEO), Maria Fardis, Ph.D. (Chairman), Maria Fardis, Ph.D., M.B.A. (Chairman and Board Member) and 6 others.
“On July 31, 2026, the Board appointed Madan Jagasia as our Chief Executive Officer and principal executive officer, Julie Feder as our Chief Financial Officer and Principal Financial Officer and Principal Accounting Officer, Parameswaran Hari as our Chief Medical Officer, and Dana Alexander as our Chief Technical Officer.”
Affiliation history
-
Current
2026-07-31–present
Company network
Leadership on record at Obsidian Therapeutics, Inc.
- Madan Jagasia CEO
- Maria Fardis, Ph.D. Chairman
- Maria Fardis, Ph.D., M.B.A. Chairman, Board Member
- Julie Feder CFO
- Heidi Hagen Board Member
- Madan Jagasia, M.D., M.S. Board Member
- Matthew Norkunas, M.D., M.B.A. Board Member
- Peter Barrett, Ph.D. Board Member
- Robert Ross, M.D. Board Member